Search results
Found 41412 matches for
Exscientia, the leading AI Drug Discovery company, has today announced its collaboration with the Alzheimer’s Research UK Oxford Drug Discovery Institute (ARUK-ODDI) to develop medicines targeting neuroinflammation for the treatment of Alzheimer’s disease (AD).
MSc in Health Service Improvement and Evaluation
MSc in Health Service Improvement and Evaluation offered by the Nuffield Department of Medicine, University of Oxford
François Nosten: Between research and humanitarian
Combining healthcare and research allow Professor Nosten to implement a new treatment regimen as soon as the results from clinical trials are available, which is beneficial to patients and highly rewarding for researchers.